Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted for publication April 11, 2017
- Published online August 1, 2017.
Article Versions
- Latest version (May 15, 2017 - 04:02).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2017
Author Information
- Dam Kim,
- Yuko Kaneko⇑ and
- Tsutomu Takeuchi
- From the Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
- YK has received consultancies, speaking fees, and/or honoraria from AbbVie Inc., Chugai Pharmaceutical Co. Ltd., and Mitsubishi Tanabe Pharma Co. TT has received consultancies, speaking fees, and/or honoraria from Astellas Pharma, Bristol–Myers K.K., Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Co., Pfizer Japan Inc., Santen Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teijin Pharma Ltd., AbbVie GK, Asahikasei Pharma Corp., Taisho Toyama Pharmaceutical Co. Ltd., SymBio Pharmaceuticals Ltd., Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co. Ltd, Nipponkayaku Co. Ltd, Astra Zeneca K.K., Eli Lilly Japan K.K., and Novartis Pharma K.K.
- D. Kim, MD, PhD, Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; Y. Kaneko, MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; T. Takeuchi, MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine.
- Address correspondence to Dr. Y. Kaneko, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan. E-mail: ykaneko{at}z6.keio.jp